84 related articles for article (PubMed ID: 27583253)
1. Successful treatment of ibrutinib-associated central nervous system hemorrhage with platelet transfusion support.
Seiter K; Stiefel MF; Barrientos J; Shaikh A; Ahmed N; Baskind P; Liu D
Stem Cell Investig; 2016; 3():27. PubMed ID: 27583253
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma.
Locke CB; Lansigan F
Cureus; 2020 Jun; 12(6):e8743. PubMed ID: 32714681
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
4. PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia.
Alberelli MA; Innocenti I; Sica S; Laurenti L; De Candia E
Thromb Res; 2016 Apr; 140 Suppl 1():S196. PubMed ID: 27161742
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy.
Miatech JL; Hughes JH; McCarty DK; Stagg MP
Case Rep Hematol; 2020; 2020():4282486. PubMed ID: 32280549
[TBL] [Abstract][Full Text] [Related]
6. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos JC; O'Brien S; Brown JR; Kay NE; Reddy NM; Coutre S; Tam C; Mulligan S; Jaeger U; Devereux S; Pocock C; Robak T; Schuster SJ; Schuh A; Gill D; Bloor A; Dearden C; Moreno C; Cull G; Hamblin M; Jones JA; Eckert K; Solman IG; Suzuki S; Hsu E; James DF; Byrd JC; Hillmen P
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):803-813.e7. PubMed ID: 30249389
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
9. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib Treatment through Nasogastric Tube in a Comatose Patient with Central Nervous System Localization of Mantle Cell Lymphoma.
Alsuliman T; Belghoul M; Choufi B
Case Rep Hematol; 2018; 2018():5761627. PubMed ID: 30186643
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
12. Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.
Mannina D; Loteta B
Case Rep Hematol; 2017; 2017():9583257. PubMed ID: 28791187
[TBL] [Abstract][Full Text] [Related]
13. Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
Heuer L; Blumenberg D
Blood Coagul Fibrinolysis; 2005 Jun; 16(4):287-90. PubMed ID: 15870549
[TBL] [Abstract][Full Text] [Related]
14. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
15. A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.
Eichenberger EM; Saullo J; Brander D; Wang SH; Perfect JR; Messina JA
Med Mycol Case Rep; 2020 Mar; 27():17-21. PubMed ID: 31879587
[TBL] [Abstract][Full Text] [Related]
16. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.
Miller CR; Ruppert AS; Heerema NA; Maddocks KJ; Labanowska J; Breidenbach H; Lozanski G; Zhao W; Gordon AL; Jones JA; Flynn JM; Jaglowski SM; Andritsos LA; Blum KA; T Awan F; Rogers KA; Grever MR; Johnson AJ; Abruzzo LV; Hertlein EK; Blachly JS; Woyach JA; Byrd JC
Blood Adv; 2017 Aug; 1(19):1584-1588. PubMed ID: 29296799
[TBL] [Abstract][Full Text] [Related]
17. Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience.
Khalid S; Yasar S; Khalid A; Spiro TP; Haddad A; Daw H
Cureus; 2018 May; 10(5):e2701. PubMed ID: 30062075
[TBL] [Abstract][Full Text] [Related]
18. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
19. Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy.
Voshtina E; Huang H; Raj R; Atallah E
Case Rep Hematol; 2018; 2018():6514604. PubMed ID: 30155323
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib.
Messina JA; Maziarz EK; Spec A; Kontoyiannis DP; Perfect JR
Open Forum Infect Dis; 2017; 4(1):ofw261. PubMed ID: 28480254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]